CasInvent Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

CasInvent General Information

Description

Developer of therapeutic compounds designed for the treatment of selected malignancies. The company uses selective inhibitors of enzymes belonging to the casein kinase family that are responsible for the migration of leukemia cells into lymphoid organs, enabling doctors to help in the treatment of leukemias, lymphomas and solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Komenského nám. 220/2
  • Brno, 602 00
  • Czech Republic
+420 728
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Komenského nám. 220/2
  • Brno, 602 00
  • Czech Republic
+420 728

CasInvent Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CasInvent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 23-Apr-2026 Completed Pre-Clinical Trials
6. Later Stage VC 01-May-2025 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jan-2024 Completed Startup
4. Early Stage VC (Series A) 01-Dec-2023 Completed Startup
3. Early Stage VC 13-Sep-2022 Completed Startup
2. Grant 01-Jan-2022 $2.26K Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view CasInvent’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CasInvent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CasInvent Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
Dendis Capital Family Office Minority
Garage Angels Angel Group Minority
Technologické inkubace Accelerator/Incubator
Bioinvestimed Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

CasInvent FAQs

  • When was CasInvent founded?

    CasInvent was founded in 2020.

  • Where is CasInvent headquartered?

    CasInvent is headquartered in Brno, Czech Republic.

  • What is the size of CasInvent?

    CasInvent has 7 total employees.

  • What industry is CasInvent in?

    CasInvent’s primary industry is Drug Discovery.

  • Is CasInvent a private or public company?

    CasInvent is a Private company.

  • What is CasInvent’s current revenue?

    The current revenue for CasInvent is .

  • How much funding has CasInvent raised over time?

    CasInvent has raised $3.03M.

  • Who are CasInvent’s investors?

    European Innovation Council, Dendis Capital, Garage Angels, Technologické inkubace, and Bioinvestimed are 5 of 11 investors who have invested in CasInvent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process